Filing Flows › Mimedx Group (MDXG) › Recalls, complaints & regulation
Mimedx Group (MDXG): clinical trials
Mimedx Group (MDXG) beyond its filings: 1 active clinical trial.
Mimedx Group's latest quarter
Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Mimedx Group have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.